Search

everythinglearnresearchcommunity

for

Search:↓

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Menopause affects hair and skin; more research needed for treatment.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

There is no significant link between male pattern baldness and insulin resistance.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.